Citi Investment Research & Analysis

Analysts at Citi Research downgraded shares of Accenture Plc (NYSE: ACN) to Neutral and lowered their price target to $86 from $88 Tuesday. Analysts outlined the logic behind the downgrade: 1) Lowered estimates. Ashwin Shirvaikar notes, "Following a 120% 5 year run, the company is...

Citi is out with a report today which discusses Exxon Mobil's (NYSE: XOM) reserves after its merger with XTO Energy. Given by XOM's preliminary report for 2010, overall proved reserves (excluding those of XTO) had decreased to 22 billion boe from an estimated 22.9 billion, mostly due to decreased...

Citi Investment Research & Analysis analyst Yaron Werber maintained a Buy/High Risk rating for shares of Genzyme Corporation (Nasdaq: GENZ), while lowering the stock's price target to $64 per share, down from the previous price target of $66. Werber said that Genzyme (GENZ) announced further (...

Citi Investment Research & Analysis analyst Josh Levin reiterated his Buy rating for shares of Beazer Homes USA Inc (NYSE: BZH), with a price target of $7 per share. Citi Investment Research & Analysis was the host of investor meetings with Beazer Homes (BZH) management in Boston yesterday...

Citi Investment Research & Analysis analysts John Boris, Morten Marott, Timothy W Chou and Nirav Jhaveri maintained their Buy/High Risk rating for shares of Mylan Inc (Nasdaq: MYL), with a price target of $23 per share. The analysts said that Mylan Inc is currently trading near the bottom of...

Citi Investment Research & Analysis analysts William R Katz and Neil Stratton rated the Och-Ziff Capital Management Group (NYSE: OZM) a High Risk, with a price target of $22 per share. The analysts said that the three biggest risks facing Och-Ziff Capital Management Group were the company's...

Citi Investment Research & Analysis analysts William R Katz and Neil Stratton rated shares of Invesco Ltd (NYSE: IVZ) a Medium Risk, with a price target of $25 per share. The analysts said that the Invesco Ltd price target of 15 x target P/E was in line with the company's peers. They said that...

Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free. Citi Investment Research & Analysis analysts William R Katz and Neil Stratton rated shares of Franklin Resources Inc (NYSE: BEN) a Low Risk, with a target price of $132 per share. The...

Citi Investment Research & Analysis analysts William R Katz and Neil Stratton rated shares of Artio Global Investors Inc (NYSE: ART) a High Risk, with a price target of $21 per share. When determining the price target, the analysts said that they applied a multiple lower than that used for the...

Citi Investment Research & Analysis analysts William R Katz and Neil Stratton rated shares of Allianceberstein Holding L.P. (NYSE: AB) Medium Risk, with a target price of $32 per share. Katz and Stratton said that because Allianceberstein Holding L.P. was in the early stages of a turnaround,...

Citi Investment Research & Analysis analysts John Boris, Morten Marott, Timothy W Chou and Nirav Jhaveri rated shares of Mylan Inc (Nasdaq: MYL) a Buy, with a target price of $23 per share. The analysts said that the management of Mylan Inc said that pricing pressure on European generic drugs...